User profiles for Massimiliano Filosto

Massimiliano Filosto

Department of Clinical and Experimental Sciences, University of Brescia, Italy
Verified email at unibs.it
Cited by 9993

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

…, C Lunetta, S Penco, N Riva, A Padovani, M Filosto… - Nature …, 2016 - nature.com
To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find
associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced …

Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions

M Filosto, SC Piccinelli, S Gazzina, C Foresti… - Journal of Neurology …, 2021 - jnnp.bmj.com
Objective Single cases and small series of Guillain-Barré syndrome (GBS) have been
reported during the SARS-CoV-2 outbreak worldwide. We evaluated incidence and clinical …

Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy

…, E Cottini, V Cristillo, I Delrio, M Filosto… - Neurology, 2020 - AAN Enterprises
Objective To report clinical and laboratory characteristics, treatment, and clinical outcomes
of patients admitted for neurologic diseases with and without coronavirus disease 2019 (…

Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γA

G Ferrari, E Lamantea, A Donati, M Filosto, E Briem… - Brain, 2005 - academic.oup.com
We studied nine infant patients with a combination of progressive neurological and hepatic
failure. Eight children, including two sibling pairs and four singletons, were affected by Alpers' …

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

…, S D'alfonso, G Sorarù, G Siciliano, M Filosto… - Nature …, 2021 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk
of one in 350 people and an unmet need for disease-modifying therapies. We conducted a …

Phenotypic heterogeneity of the 8344A> G mtDNA “MERRF” mutation

…, G Uziel, C Bruno, E Caldarazzo Ienco, M Filosto… - Neurology, 2013 - AAN Enterprises
Objectives: Myoclonic epilepsy with ragged-red fibers (MERRF) is a rare mitochondrial
syndrome, mostly caused by the 8344A>G mitochondrial DNA mutation. Most of the previous …

Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3

…, R Mantegazza, R Liguori, M Filosto… - Journal of Neurology …, 2020 - jnnp.bmj.com
Objective To retrospectively investigate safety and efficacy of nusinersen in a large cohort of
adult Italian patients with spinal muscular atrophy (SMA). Methods Inclusion criteria were: (1…

The role of mitochondria in neurodegenerative diseases

M Filosto, M Scarpelli, MS Cotelli, V Vielmi… - Journal of …, 2011 - Springer
Mitochondria are implicated in several metabolic pathways including cell respiratory
processes, apoptosis, and free radical production. Mitochondrial abnormalities have been …

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy

…, K Orchard, M Collin, D Valcarcel, A Rovelli, M Filosto… - Brain, 2015 - academic.oup.com
Haematopoietic stem cell transplantation has been proposed as treatment for mitochondrial
neurogastrointestinal encephalomyopathy, a rare fatal autosomal recessive disease due to …

The m. 3243A> G mitochondrial DNA mutation and related phenotypes. A matter of gender?

…, A Toscano, G Uziel, C Bruno, EC Ienco, M Filosto… - Journal of …, 2014 - Springer
The m.3243A>G “MELAS” (mitochondrial encephalopathy with lactic acidosis and stroke-like
episodes) mutation is one of the most common point mutations of the mitochondrial DNA, …